NCT05842174 2026-01-22
TAQE
VA Office of Research and Development
Phase 1/2 Not yet recruiting
Clinical Trials
22 trialsNCT04459468 2026-01-08
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
University of Texas Southwestern Medical Center
Completed
NCT03727633 2026-01-05
LIDA-BII
University Hospital, Montpellier
Phase 2 Recruiting
NCT06632717 2025-11-25
Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 2 Recruiting
NCT02174549 2024-11-22
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Teclison Ltd.
Phase 1/2 Recruiting
NCT02762266 2024-03-12
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Stanford University
Phase 3 Terminated
NCT05291338 2023-07-28
Pharmacogenetic Study in Hepatocellular Carcinoma Patients.
Damanhour University
Completed
NCT01387932 2021-11-30
HiQuality
Merit Medical Systems, Inc.
Phase 3 Terminated
NCT02971345 2020-06-11
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT01877187 2020-04-15
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Yale University
Phase 2 Completed
NCT04048317 2019-08-07
Effectiveness of Drug Eluting TACE in Primary HCC
Assiut University
Phase EARLY_PHASE1 Unknown
NCT02585479 2019-06-04
Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma
Guangxi Medical University
Phase 2/3 Withdrawn
NCT01229839 2019-03-06
Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC
Sun Yat-sen University
Phase 3 Completed
NCT03192644 2017-06-20
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sun Yat-sen University
Phase 3 Unknown
NCT01966133 2017-01-09
TACE as an Adjuvant Therapy After Hepatectomy for HCC
Fudan University
Phase 3 Unknown
NCT02630108 2016-10-18
TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT02755311 2016-04-28
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT00820053 2016-04-01
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
Eastern Hepatobiliary Surgery Hospital
Phase 2 Completed
NCT02631499 2015-12-22
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
Fudan University
Phase 4 Unknown
NCT01861912 2013-06-05
ACTION
Guangdong Provincial People's Hospital
Phase 2/3 Unknown
NCT00870558 2011-08-16
Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00470340 2011-05-05
GEMOXIAL
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated